Multiparametric MRI of early tumor response to immune checkpoint blockade in metastatic melanoma

BACKGROUND: Immune checkpoint inhibitors are now standard of care treatment for many cancers. Treatment failure in metastatic melanoma is often due to tumor heterogeneity, which is not easily captured by conventional CT or tumor biopsy. The aim of this prospective study was to investigate early micr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lau, Doreen, McLean, Mary A, Priest, Andrew N, Gill, Andrew B, Scott, Francis, Patterson, Ilse, Carmo, Bruno, Riemer, Frank, Kaggie, Joshua D, Frary, Amy, Milne, Doreen, Booth, Catherine, Lewis, Arthur, Sulikowski, Michal, Brown, Lee, Lapointe, Jean-Martin, Aloj, Luigi, Graves, Martin J, Brindle, Kevin M, Corrie, Pippa G, Gallagher, Ferdia A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Immunotherapy Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475139/
https://www.ncbi.nlm.nih.gov/pubmed/34561275
http://dx.doi.org/10.1136/jitc-2021-003125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475139/
https://www.ncbi.nlm.nih.gov/pubmed/34561275
http://dx.doi.org/10.1136/jitc-2021-003125

Ejemplares similares